Gabapentin Tablet, Coated
Product Images NDC 83301-0002

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 83301-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of the active ingredient gabapentin, showing a cyclohexane ring attached to an amino group (CH2NH2) and an acetic acid group (CH2CO2H).*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph showing mean pain scores over an 8-week period, comparing placebo and Gabapentin at 3,600 mg/day. The x-axis represents time in weeks from baseline through 8 weeks, while the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period, illustrating the decreasing pain scores for Gabapentin compared to placebo.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph depicting the mean pain score over a period of 7 weeks, including a 3-week dose titration period and a 4-week fixed dose period. The graph compares three groups: placebo, gabapentin 1,800 mg/day, and gabapentin 2,400 mg/day, showing trends of pain score changes from baseline through week 7.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart comparing percentages from two studies involving gabapentin (GBP) and placebo (PBO). Study 1 shows 12% for placebo and 29% for gabapentin 3,600 mg. Study 2 shows 14% for placebo, 32% for gabapentin 1,800 mg, and 34% for gabapentin 2,400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A bar chart showing percentage differences in a variable across three studies (Study a, Study b, Study c) at various gabapentin daily doses (600 mg, 900 mg, 1,200 mg, 1,800 mg). Differences range approximately from 7% to 19% and are labeled with letters to indicate statistical comparisons within doses.*

FDA Label Image

Gabapentin 600 mg Tablet Bottle Label (Gabapentin 600 mg Tablet Bottle Label)

Gabapentin Tablets USP 600 mg coated oral tablets label by Mullan Pharmaceutical Inc. The label indicates a package of 100 tablets, pharmacy dispensing instructions, storage conditions, and includes a barcode and QR code. The manufacturer is CSPC Ouyi Pharmaceutical Co., Ltd.*

FDA Label Image

Gabapentin 800 mg Tablet Bottle Label (Gabapentin 800 mg Tablet Bottle Label)

Gabapentin Tablets USP 800 mg film-coated oral tablets label. The rectangular label indicates the product is manufactured for Mullan Pharmaceutical Inc. and contains 100 tablets. It includes dosage strength, storage instructions, and a barcode alongside a QR code for additional product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.